| Dr Elizabeth Keith Elkinson, MD | |
|
910 Wallace Ave Ste 302, Leitchfield, KY 42754-2418 | |
| (270) 259-2700 | |
| (270) 259-2717 |
| Full Name | Dr Elizabeth Keith Elkinson |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 20 Years |
| Location | 910 Wallace Ave Ste 302, Leitchfield, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528251741 | NPI | - | NPPES |
| 7100056670 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 42388 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Orthopedic Rehabilitation Llc | 0345157293 | 683 |
| New Lexington Clinic, Psc | 3476457532 | 310 |
News Archive
Scientists have made a breakthrough in understanding how the enteric nervous system forms, which could pave the way for new treatments for neurodegenerative diseases such as Parkinson's.
Despite compelling evidence about the benefits of breastfeeding little is known about the breastfeeding experiences of mothers of infants with Down's syndrome. In the UK, clinical commissioning groups and practitioners have a vital role in empowering and enabling these women to access help and support as soon as the child is born.
According to new international research, just less than one per cent of the population is naturally protected against developing chronic coronary artery diseases.
The University of Arizona Center for Innovation in Brain Science has received a $37.5 million grant from the National Institutes of Health to research a potential regenerative therapy for Alzheimer's disease.
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 8 days ago
| Entity Name | New Lexington Clinic Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700803681 PECOS PAC ID: 3476457532 Enrollment ID: O20031121000103 |
News Archive
Scientists have made a breakthrough in understanding how the enteric nervous system forms, which could pave the way for new treatments for neurodegenerative diseases such as Parkinson's.
Despite compelling evidence about the benefits of breastfeeding little is known about the breastfeeding experiences of mothers of infants with Down's syndrome. In the UK, clinical commissioning groups and practitioners have a vital role in empowering and enabling these women to access help and support as soon as the child is born.
According to new international research, just less than one per cent of the population is naturally protected against developing chronic coronary artery diseases.
The University of Arizona Center for Innovation in Brain Science has received a $37.5 million grant from the National Institutes of Health to research a potential regenerative therapy for Alzheimer's disease.
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 8 days ago
| Entity Name | Owensboro Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235518242 PECOS PAC ID: 0648255034 Enrollment ID: O20040621000818 |
News Archive
Scientists have made a breakthrough in understanding how the enteric nervous system forms, which could pave the way for new treatments for neurodegenerative diseases such as Parkinson's.
Despite compelling evidence about the benefits of breastfeeding little is known about the breastfeeding experiences of mothers of infants with Down's syndrome. In the UK, clinical commissioning groups and practitioners have a vital role in empowering and enabling these women to access help and support as soon as the child is born.
According to new international research, just less than one per cent of the population is naturally protected against developing chronic coronary artery diseases.
The University of Arizona Center for Innovation in Brain Science has received a $37.5 million grant from the National Institutes of Health to research a potential regenerative therapy for Alzheimer's disease.
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 8 days ago
| Entity Name | Obhg Kentucky Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457644122 PECOS PAC ID: 5496910200 Enrollment ID: O20120628000666 |
News Archive
Scientists have made a breakthrough in understanding how the enteric nervous system forms, which could pave the way for new treatments for neurodegenerative diseases such as Parkinson's.
Despite compelling evidence about the benefits of breastfeeding little is known about the breastfeeding experiences of mothers of infants with Down's syndrome. In the UK, clinical commissioning groups and practitioners have a vital role in empowering and enabling these women to access help and support as soon as the child is born.
According to new international research, just less than one per cent of the population is naturally protected against developing chronic coronary artery diseases.
The University of Arizona Center for Innovation in Brain Science has received a $37.5 million grant from the National Institutes of Health to research a potential regenerative therapy for Alzheimer's disease.
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elizabeth Keith Elkinson, MD 520 Sayre Ave, Lexington, KY 40508-2316 Ph: (859) 537-2514 | Dr Elizabeth Keith Elkinson, MD 910 Wallace Ave Ste 302, Leitchfield, KY 42754-2418 Ph: (270) 259-2700 |
News Archive
Scientists have made a breakthrough in understanding how the enteric nervous system forms, which could pave the way for new treatments for neurodegenerative diseases such as Parkinson's.
Despite compelling evidence about the benefits of breastfeeding little is known about the breastfeeding experiences of mothers of infants with Down's syndrome. In the UK, clinical commissioning groups and practitioners have a vital role in empowering and enabling these women to access help and support as soon as the child is born.
According to new international research, just less than one per cent of the population is naturally protected against developing chronic coronary artery diseases.
The University of Arizona Center for Innovation in Brain Science has received a $37.5 million grant from the National Institutes of Health to research a potential regenerative therapy for Alzheimer's disease.
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
› Verified 8 days ago
James Samuel Buck, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 910 Wallace Ave, Leitchfield, KY 42754 Phone: 270-259-2700 Fax: 270-259-2717 | |
Gary E Yochim, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 910 Wallace Ave, Ste 301, Leitchfield, KY 42754 Phone: 270-259-9651 | |
Mark J Lee, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 910 Wallace Ave, Leitchfield, KY 42754 Phone: 270-259-2700 Fax: 270-259-2717 |